Documents in Dekker v. Weida

Court documents in the archive for this case, each with the description the archive holds and a link to the original where there is one. Documents are listed by docket entry; an attachment sits under its entry, marked with the entry number and its own number (12-3 is the third attachment to entry 12). 1,052 documents.

Court documents
EntryDateDocumentPagesOpen
170-1Exhibit Expert Witness Declaration of Paul W Hruz MD PhDDocket 4:22-cv-00325115View here · Original(opens another site)PDF, external
171ORDER ALLOWING ABDUL-LATIF AMICUS BRIEF. The unopposed motion of Hussein Abdul-Latif et al., ECF No. 168, for leave to file an amicus brief in opposition to the defendants' summary-judgment motion is granted. The amicus brief, ECF No. 169, is deemed properly filed. Signed by JUDGE ROBERT L HINKLE on 4/25/2023. (rcb) (Entered: 04/25/2023)Order on Motion for Leave to File · Docket 4:22-cv-003251View here · Original(opens another site)PDF, external
172AMENDED DOCUMENT by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN. Amendment to 162 Rule 26 Disclosures . (SHAW, GARY) (Entered: 04/25/2023)Amended Document · Docket 4:22-cv-0032553View here · Original(opens another site)PDF, external
173USCA ORDER- Appeal # 23-11126. Accordingly, the Petition for a Writ of Mandamus is DENIED. (rcb) (Entered: 04/27/2023)USCA Acknowledgment · Docket 4:22-cv-003253View here · Original(opens another site)PDF, external
174Consent MOTION to Seal Certain Trial Exhibits by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN. (Attachments: # 1 Exhibit 299 - Email communication between AHCA and Magellan regarding coverage of GnRH to treat gender dysphoria) (MILLER, WILLIAM) (Entered: 04/27/2023)Motion to Seal · Docket 4:22-cv-003255View here · Original(opens another site)PDF, external
175PLAINTIFFS' NOTICE OF FILING TRIAL EXHIBITS. (Attachments: # 1 Exhibit 1 - Defendants Response to Pls First Set of Request for Admissions, # 2 Exhibit 2 - Defendants Response to Pls First Set of Interrogatories, # 3 Exhibit 3 - Defendants Response to Pls Second Set of Interrogatories, # 4 Exhibit 4 - Pls First Set of Request for Admissions, # 5 Exhibit 5 - Expert report of Dr. Armand H. Antommaria 2/16/2023, # 6 Exhibit 6 - Expert report of Kellan E. Baker, M.A., M.P.H., PhD 2/17/2023, # 7 Exhibit 7 - Expert report of Dr. Dan H. Karasic 2/15/2023, # 8 Exhibit 8 - Expert report of Dr. Johanna Olson-Kennedy 2/16/2023, # 9 Exhibit 9 - Expert report of Dr. Daniel Shumer 2/16/2023, # 10 Exhibit 10 - Expert report of Dr. Loren S. Schecter 2/16/2023, # 11 Exhibit 11 - Expert rebuttal report of Dr. Dan H. Karasic 3/9/2023, # 12 Exhibit 12 - Expert rebuttal report of Dr. Johanna Olson-Kennedy 3/9/2023, # 13 Exhibit 13 - Expert rebuttal report of Dr. Loren S. Schechter 3/9/2023, # 14 Exhibit 14 - Expert rebuttal report of Dr. Armand H. Antommaria 3/10/2023, # 15 Exhibit 15 - Corrected expert rebuttal report of Dr. E. Kale Edmiston 3/22/2023, # 16 Exhibit 16 - Expert rebuttal report of Dr. Daniel Shumer 3/10/2023, # 17 Exhibit 17 - Expert rebuttal report of Dr. Aron Janssen 3/9/2023, # 18 Exhibit 18 - AHCA GAPMS June 2022, # 19 Exhibit 19 - Marstiller Letter to Wallace re AHCA June 2022 GAPMS, # 20 Exhibit 20 - Fla. Admin. Code R. 59G-1.050, # 21 Exhibit 21 - Fla. Admin. Code R. 59G-1.010, # 22 Exhibit 22 - Florida Medicaid Definitions Policy (Aug. 2017), # 23 Exhibit 23 - Fla. Admin. Code R. 59G-1.035, # 24 Exhibit 24 - AHCAs Automated Prior Authorizations and Bypass Lists 01-2023, # 25 Exhibit 25 - DRUGDEX listing for Testosterone, # 26 Exhibit 26 - DRUGDEX listing for Estradiol, # 27 Exhibit 27 - Prior Authorization Criteria - Testosterone, # 28 Exhibit 28 - Agency Responses to Plaintiffs Questions: March 1, 2023, # 29 Exhibit 29 - 2020-2021 Performance Plan for Jeffrey English, # 30 Exhibit 30 - Email communication between Jeffrey English and Devona Pickle 3/22/22, # 31 Exhibit 31 - AHCA Analysis of Other States Medicaid Coverage, # 32 Exhibit 32 - Miriam Grossman biography, # 33 Exhibit 33 - DSM 5 Gender Dysphoria, # 34 Exhibit 34 - WPATH Standards of Care for the Health of Transgender and Gender Diverse People, Version 8, # 35 Exhibit 35 - WPATH Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People, Version 7, # 36 Exhibit 36 - AACAP Statement Responding to Efforts to Ban Care (Nov. 8, 2019), # 37 Exhibit 37 - AAFP Care for Transgender Patients, # 38 Exhibit 38 - AAP Ensuring Comprehensive Care and Support, # 39 Exhibit 39 - ACOG Committee Opinion on Health Care for Transgender Individuals (March 2021), # 40 Exhibit 40 - ACP Attacks on Gender-Affirming and Transgender Health Care (May 3, 2022)) (MILLER, WILLIAM) Modified to edit title on 4/28/2023 (rcb). (Entered: 04/27/2023)Exhibit List · Docket 4:22-cv-0032515View here · Original(opens another site)PDF, external
175-1Exhibit 1 - Defendants Response to Pls First Set of Request for AdmissionsExhibit 1 - Defendants Response to Pls First Set of Request · Docket 4:22-cv-0032520View here · Original(opens another site)PDF, external
175-2Exhibit 2 - Defendants Response to Pls First Set of InterrogatoriesExhibit 2 - Defendants Response to Pls First Set of Interrog · Docket 4:22-cv-0032522View here · Original(opens another site)PDF, external
175-3Exhibit 3 - Defendants Response to Pls Second Set of InterrogatoriesExhibit 3 - Defendants Response to Pls Second Set of Interro · Docket 4:22-cv-0032512View here · Original(opens another site)PDF, external
175-4Exhibit 4 - Pls First Set of Request for AdmissionsDocket 4:22-cv-0032520View here · Original(opens another site)PDF, external
175-5Exhibit 5 - Expert report of Dr. Armand H. Antommaria 2/16/2023Exhibit 5 - Expert report of Dr. Armand H. Antommaria 2/16/ · Docket 4:22-cv-0032571View here · Original(opens another site)PDF, external
175-6Exhibit 6 - Expert report of Kellan E. Baker, M.A., M.P.H., PhD 2/17/2023Exhibit 6 - Expert report of Kellan E. Baker, M.A., M.P.H., · Docket 4:22-cv-0032558View here · Original(opens another site)PDF, external
175-7Exhibit 7 - Expert report of Dr. Dan H. Karasic 2/15/2023Docket 4:22-cv-0032568View here · Original(opens another site)PDF, external
175-8Exhibit 8 - Expert report of Dr. Johanna Olson-Kennedy 2/16/2023Exhibit 8 - Expert report of Dr. Johanna Olson-Kennedy 2/16 · Docket 4:22-cv-00325105View here · Original(opens another site)PDF, external
175-9Exhibit 9 - Expert report of Dr. Daniel Shumer 2/16/2023Docket 4:22-cv-0032559View here · Original(opens another site)PDF, external
175-10Exhibit 10 - Expert report of Dr. Loren S. Schecter 2/16/2023Exhibit 10 - Expert report of Dr. Loren S. Schecter 2/16/20 · Docket 4:22-cv-00325111View here · Original(opens another site)PDF, external
175-11Exhibit 11 - Expert rebuttal report of Dr. Dan H. Karasic 3/9/2023Exhibit 11 - Expert rebuttal report of Dr. Dan H. Karasic 3 · Docket 4:22-cv-0032539View here · Original(opens another site)PDF, external
175-12Exhibit 12 - Expert rebuttal report of Dr. Johanna Olson-Kennedy 3/9/2023Exhibit 12 - Expert rebuttal report of Dr. Johanna Olson-Ken · Docket 4:22-cv-0032557View here · Original(opens another site)PDF, external
175-13Exhibit 13 - Expert rebuttal report of Dr. Loren S. Schechter 3/9/2023Exhibit 13 - Expert rebuttal report of Dr. Loren S. Schechte · Docket 4:22-cv-0032517View here · Original(opens another site)PDF, external
175-14Exhibit 14 - Expert rebuttal report of Dr. Armand H. Antommaria 3/10/2023Exhibit 14 - Expert rebuttal report of Dr. Armand H. Antomma · Docket 4:22-cv-0032540View here · Original(opens another site)PDF, external
175-15Exhibit 15 - Corrected expert rebuttal report of Dr. E. Kale Edmiston 3/22/2023Exhibit 15 - Corrected expert rebuttal report of Dr. E. Kale · Docket 4:22-cv-0032548View here · Original(opens another site)PDF, external
175-16Exhibit 16 - Expert rebuttal report of Dr. Daniel Shumer 3/10/2023Exhibit 16 - Expert rebuttal report of Dr. Daniel Shumer 3/ · Docket 4:22-cv-0032549View here · Original(opens another site)PDF, external
175-17Exhibit 17 - Expert rebuttal report of Dr. Aron Janssen 3/9/2023Exhibit 17 - Expert rebuttal report of Dr. Aron Janssen 3/9 · Docket 4:22-cv-0032572View here · Original(opens another site)PDF, external
175-18Exhibit 18 - AHCA GAPMS June 2022Docket 4:22-cv-0032546View here · Original(opens another site)PDF, external
175-19Exhibit 19 - Marstiller Letter to Wallace re AHCA June 2022 GAPMSExhibit 19 - Marstiller Letter to Wallace re AHCA June 2022 · Docket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-20Exhibit 20 - Fla. Admin. Code R. 59G-1.050Docket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-21Exhibit 21 - Fla. Admin. Code R. 59G-1.010Docket 4:22-cv-003251View here · Original(opens another site)PDF, external
175-22Exhibit 22 - Florida Medicaid Definitions Policy (Aug. 2017)Docket 4:22-cv-0032512View here · Original(opens another site)PDF, external
175-23Exhibit 23 - Fla. Admin. Code R. 59G-1.035Docket 4:22-cv-003251View here · Original(opens another site)PDF, external
175-24Exhibit 24 - AHCAs Automated Prior Authorizations and Bypass Lists 01-2023Exhibit 24 - AHCAs Automated Prior Authorizations and Bypass · Docket 4:22-cv-00325109View here · Original(opens another site)PDF, external
175-25Exhibit 25 - DRUGDEX listing for TestosteroneDocket 4:22-cv-00325168View here · Original(opens another site)PDF, external
175-26Exhibit 26 - DRUGDEX listing for EstradiolDocket 4:22-cv-00325270View here · Original(opens another site)PDF, external
175-27Exhibit 27 - Prior Authorization Criteria - TestosteroneDocket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-28Exhibit 28 - Agency Responses to Plaintiffs Questions: March 1, 2023Exhibit 28 - Agency Responses to Plaintiffs Questions: March · Docket 4:22-cv-003253View here · Original(opens another site)PDF, external
175-29Exhibit 29 - 2020-2021 Performance Plan for Jeffrey EnglishDocket 4:22-cv-0032515View here · Original(opens another site)PDF, external
175-30Exhibit 30 - Email communication between Jeffrey English and Devona Pickle 3/22Exhibit 30 - Email communication between Jeffrey English and · Docket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-31Exhibit 31 - AHCA Analysis of Other States Medicaid CoverageDocket 4:22-cv-003251View here · Original(opens another site)PDF, external
175-32Exhibit 32 - Miriam Grossman biographyDocket 4:22-cv-003253View here · Original(opens another site)PDF, external
175-33Exhibit 33 - DSM 5 Gender DysphoriaDocket 4:22-cv-003259View here · Original(opens another site)PDF, external
175-34Exhibit 34 - WPATH Standards of Care for the Health of Transgender and Gender DiExhibit 34 - WPATH Standards of Care for the Health of Trans · Docket 4:22-cv-00325260View here · Original(opens another site)PDF, external
175-35Exhibit 35 - WPATH Standards of Care for the Health of Transsexual, Transgender,Exhibit 35 - WPATH Standards of Care for the Health of Trans · Docket 4:22-cv-00325120View here · Original(opens another site)PDF, external
175-36Exhibit 36 - AACAP Statement Responding to Efforts to Ban Care (Nov. 8, 2019)Exhibit 36 - AACAP Statement Responding to Efforts to Ban Ca · Docket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-37Exhibit 37 - AAFP Care for Transgender PatientsDocket 4:22-cv-003252View here · Original(opens another site)PDF, external
175-38Exhibit 38 - AAP Ensuring Comprehensive Care and SupportDocket 4:22-cv-0032514View here · Original(opens another site)PDF, external
175-39Exhibit 39 - ACOG Committee Opinion on Health Care for Transgender Individuals (Exhibit 39 - ACOG Committee Opinion on Health Care for Trans · Docket 4:22-cv-0032514View here · Original(opens another site)PDF, external
175-40Exhibit 40 - ACP Attacks on Gender-Affirming and Transgender Health Care (May 3Exhibit 40 - ACP Attacks on Gender-Affirming and Transgende · Docket 4:22-cv-003255View here · Original(opens another site)PDF, external
176Exhibit List (Notice of Filing, Part 2 of 10) by AUGUST DEKKER, JANE DOE, JOHN DOE, SUSAN DOE, K F, JADE LADUE, BRIT ROTHSTEIN.. (Attachments: # 1 Exhibit 41 - LGBT Health Disparities Policy, ACOP, # 2 Exhibit 42 - AMA Letter to Natl Gov. Assoc. (April 26, 2021), # 3 Exhibit 43 - AMA/GLMA Issue Brief on health insurance coverage for gender-affirming care, # 4 Exhibit 44 - AMA Resolution H-185.950, # 5 Exhibit 45 - APA, Guidelines for Psychological Practice with Transgender and Gender Non-conforming People, # 6 Exhibit 46 - APA Resolution on Gender Identity Change Efforts (Feb. 2021), # 7 Exhibit 47 - APA Position Statement Trans and Gender Diverse Youth (July 2020), # 8 Exhibit 48 - APA Position Statement on Access to Care (July 2018), # 9 Exhibit 49 - Endocrine Society Transgender Health Position Statement, # 10 Exhibit 50 - Pediatric Endocrine Society Opposition to Bills that Harm Transgender Youth (April 2021), # 11 Exhibit 51 - SAHM Statement in Opposition of State Legislation Barring Evidence Based Treatment, # 12 Exhibit 52 - WMA Statement on Transgender People (Oct. 2015), # 13 Exhibit 53 - Van Meter Pediatric Endocrinology Excerpt, # 14 Exhibit 54 - Humana Pharmacy Coverage Policy, commercial insurance coverage policy for testosterone 5/18/2022, # 15 Exhibit 55 - Aetna Clinical Policy Bulletin, coverage of Progestins 4/27/2023, # 16 Exhibit 56 - Aetna, Clinical Policy Bulletin, gender affirming surgery 6/22/2023, # 17 Exhibit 57 - Aetna, Clinical Policy Bulletin, GnRHa 2/23/2023, # 18 Exhibit 58 - Humana, Medical Coverage Policy, cover of gender affirmation surgery 9/22/2022, # 19 Exhibit 59 - Molina Healthcare, Coverage criteria for Gender Dysphoria Hormone Therapy July 2023, # 20 Exhibit 60 - Molina Clinical Policy, Gender Affirmation Treatment and Procedures (Marketplace) - 2/8/2023, # 21 Exhibit 61 - UHC Gender Dysphoria Treatment (commercial), 4/1/2023, # 22 Exhibit 62 - Ctrs. for Medicare & Medicaid Servs., EPSDT A Guide for States: Coverage in the Medicaid Benefit for Children and Adolescents, # 23 Exhibit 63 - Ctrs. for Medicare & Medicaid Servs., CMCS Informational Bulletin (July 21, 2022), # 24 Exhibit 64 - Ctrs. for Medicare & Medicaid Servs., Decision Memo for Gender Dysphoria and Surgery (Aug. 20, 2016), # 25 Exhibit 65 - Office of the Press Secretary, Presidential Memo (Aug. 25, 2017), # 26 Exhibit 66 - FDA, Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products (Draft Guidance) (2018), # 27 Exhibit 67 - FDA, Understanding Unapproved Use of Approved Drugs "Off Label," (2018), # 28 Exhibit 68 - U.S. Drug Enforcement Administration, Drug Scheduling, July 10, 2018, # 29 Exhibit 69 - U.S. Comm. on Civil Rights Statement on State Laws Targeting LGBTQ Community, (April 18, 2016), # 30 Exhibit 70 - U.S. Comm. on Civil Rights Statement on Military Ban (Aug. 18, 2017), # 31 Exhibit 71 - Dept of Health & Human Servs., Departmental Appeals Bd., Appellate Div., Decision No. 2576 (May 30, 2014), # 32 Exhibit 72 - OASH, Gender-Affirming Care and Young People, # 33 Exhibit 73 - SAMHSA, Ending Conversion Therapy (Oct. 2015), # 34 Exhibit 74 - SAMHSA, Moving Beyond Change Efforts (2023), # 35 Exhibit 75 - NCTSN, Gender-Affirming Care is Trauma-Informed Care, # 36 Exhibit 76 - U.S. Presidential Proclamation, Transgender Day of Visibility, 2022, # 37 Exhibit 77 - U.S. Presidential Proclamation, Transgender Day of Visibility, 2023, # 38 Exhibit 78 - Executive Order, Preventing and Combating Discrimination on the Basis of Gender Identity or Sexual Orientation (Jan. 20, 2021), # 39 Exhibit 79 - Medicaid Coverage for Gender-Affirming Care, Williams Institute (Dec. 2022), # 40 Exhibit 80 - Excerpts from trial transcript Vol. 5 (Levine), Brandt v. Rutledge, 4:21-CV-00450-JM (E.D. Ark.)) (MILLER, WILLIAM) (Entered: 04/27/2023)Exhibit List · Docket 4:22-cv-0032547View here · Original(opens another site)PDF, external
176-1Exhibit 41 - LGBT Health Disparities Policy, ACOPDocket 4:22-cv-0032542View here · Original(opens another site)PDF, external
176-2Exhibit 42 - AMA Letter to Natl Gov. Assoc. (April 26, 2021)Docket 4:22-cv-003252View here · Original(opens another site)PDF, external
176-3Exhibit 43 - AMA/GLMA Issue Brief on health insurance coverage for gender-affirmExhibit 43 - AMA/GLMA Issue Brief on health insurance covera · Docket 4:22-cv-003255View here · Original(opens another site)PDF, external